Inhibition of GSK3β was shown to reduce apoptosis and proteolysis in MFS VSMC cultures derived from multiple different patients and additionally corrects the abnormal fibrillin-1 deposition associated with MFS, potentially identifying it as one of the key components of the disease phenotype [260]. This evidence concerns the gene FBN1 and Marfan syndrome.